FGF21 Antibody | CSB-PA290047

(No reviews yet) Write a Review
SKU:
CSB-PA290047
Availability:
3 to 7 Working Days
  • FGF21 Antibody
  • The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA290047 (FGF21 Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: ×200)
  • The image on the left is immunohistochemistry of paraffin-embedded Human brain tissue using CSB-PA290047 (FGF21 Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: ×200)
€315.80 - €488.70

Description

FGF21 Antibody | CSB-PA290047 | Cusabio

FGF21 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: FGF21

Aliases: fibroblast growth factor 21

Background: The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. The function of this growth factor has not yet been determined.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q9NSA1

Host Species: Rabbit

Species Reactivity: Human, Mouse

Immunogen: Fusion protein of human FGF21

Immunogen Species: Human

Applications: ELISA, IHC

Tested Applications: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

Purification Method: Antigen affinity purification

Dilution Ratio1: ELISA:1:1000-1:2000

Dilution Ratio2: IHC:1:25-1:100

Dilution Ratio3:

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Cardiovascular

Research Areas: Cancer;Cardiovascular;Signal transduction

View AllClose

0 Reviews

View AllClose